Browse

Explore conditions, clinical trials, and the organisations running them.

Up to: Movement disorder · Synucleinopathy

Multiple system atrophy

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years.

110 trials tagged with this condition →

Pure autonomic failure 18 trials
Multiple system atrophy, parkinsonian type 12 trials
Multiple system atrophy, cerebellar type 3 trials
Striatonigral degeneration 0 trials Sub-types →